Suchergebnisse - "Parfrey, Patrick S"

PubPharm (10)

1

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Sarnak, M. | Agarwal, R. | Boudville, N. | +12

2

Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease

enthalten in: American journal of hematology | 2022

von Koury, M. | Agarwal, R. | Chertow, G. | +16

3

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials

enthalten in: American journal of nephrology | 2022

von Agarwal, R. | Anand, S. | Eckardt, K. | +7

4

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis

enthalten in: The New England journal of medicine | 2021

von Eckardt, K. | Agarwal, R. | Aswad, A. | +25

CommentIn: N Engl J Med. 2021 Apr 29;384(17):1657-1658. - PMID 33913643

5

Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD

enthalten in: The New England journal of medicine | 2021

von Chertow, G. | Pergola, P. | Farag, Y. | +128

CommentIn: N Engl J Med. 2021 Apr 29;384(17):1657-1658. - PMID 33913643

6

Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus

enthalten in: American heart journal | 2015

von Lewis, E. | Claggett, B. | Parfrey, P. | +9

7

Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes : an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2013

von Skali, H. | Lin, J. | Pfeffer, M. | +12

CommentIn: Am J Kidney Dis. 2013 Feb;61(2):191-3. - PMID 23318011

8

Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa : the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience

enthalten in: Circulation | 2011

von Skali, H. | Parving, H. | Parfrey, P. | +11

CommentIn: Circulation. 2011 Dec 20;124(25):2805-8. - PMID 22184042

9

Darbepoetin alfa impact on health status in diabetes patients with kidney disease : a randomized trial

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2011

von Lewis, E. | Pfeffer, M. | Feng, A. | +10

10

Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) : evolving the management of cardiovascular risk in patients with chronic kidney disease

enthalten in: American heart journal | 2005

von Mix, T. | Brenner, R. | Cooper, M. | +14

ErratumIn: Am Heart J. 2005 Jul;150(1):53

1
[1]